Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Healthcare Collaboration and Partnerships


Excellence in Healthcare Collaboration and Partnerships

Health providers such as the NHS and the pharmaceutical industry share a common agenda to improve patient care outcomes through high quality, cost effective treatment and management. 


The common agenda is to improve patient outcomes through joint working to ensure that patients get optimal care, with support to help them maximise the benefits of treatment. 


Eligible work will demonstrate joint development and implementation of patient-centred projects together with shared commitment to successful delivery. These may have operated at a local or national level.


This category relates to work carried out between July 2011 and December 2012.


Potential entrants might include:


  • Pharmaceutical company brand teams
  • Pharmaceutical company communications teams
  • Healthcare agencies and consultancies. 


Judging criteria:


  • Clear understanding of customer needs and objectives
  • Demonstration of partnership between (two or more) players:
  • shared objectives
  • pooled skills, experience and/or resources 
  • Evidence of sustained relationships and mutual benefit
  • Evidence of changed behaviours and enhanced health outcomes 
  • Customer feedback

Sponsors

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...

Infographics